Repligen is headquartered in Waltham, Massachusetts.
Repligen disclosed revenue of 634M USD for 2024 and 632M USD for 2023.
Repligen has 1,778 employees.
Repligen is a life science company.
Repligen was founded in 1981.
Building 1 Suite 100 41 Seyon Street,
Waltham, Massachusetts
02453
United States,
(781) 250-0111
www.repligen.com
Repligen is a life sciences company focused on the development and commercialization of high-value consumable products used in the process of manufacturing biological drugs. Repligen was founded in 1981 and is based in Waltham, Massachusetts.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.8/yr) | # | 7 | 2 | - | 1 | 1 | - | 11 |
| vol | $979M | $150M | $1.1B | |||||
| Sell (0.2/yr) | # | - | 1 | - | - | - | - | 1 |
| 12 | ||||||||
| Financial | Deals |
|---|---|
|
Perella Weinberg Partners |
6 |
|
EC M&A |
2 |
|
Stifel |
1 |
| Legal | Deals |
|---|---|
|
Goodwin Procter |
9 |
|
Advokatfirman Vinge |
1 |
|
Tsar & Tsai Law Firm |
1 |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
